Under 18, any sex, with Laceration. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Cosmetic Outcome of Scar at 3 MonthsPrimary· 3 months
Two blinded Plastic Surgeons will rate the cosmetic outcome of the laceration using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "worst scar" and a score of 100 corresponding to "best scar"
Group
Value
95% CI
Absorbable Sutures
64.00
51.00 – 76.00
Steri-Strips
54.00
35.50 – 66.75
Dermabond
48.50
29.50 – 78.75
Pain Experienced by Patient as Reported by ParentSecondary· Baseline
Parents will each be asked to score how much pain they felt the patient experienced using a 100 mm Visual Analogue Scale with a score of 0 corresponding to "No pain" and a score of 100 corresponding to "Terrible pain."
Group
Value
95% CI
Absorbable Sutures
17.00
1.50 – 51.50
Steri-Strips
22.00
9.00 – 28.00
Dermabond
11.00
3.00 – 24.50
Satisfaction With Time in the Emergency DepartmentSecondary· Baseline to wound closure, up to 30 minutes
Parents will report their satisfaction with Emergency Department length of stay using a 100-point visual analog scale with "100" meaning completely satisfied and "0" meaning not at all satisfied
Group
Value
95% CI
Absorbable Sutures
89.50
45.25 – 98.50
Steri-Strips
92.00
83.00 – 100.00
Dermabond
94.00
71.25 – 100.00
Likelihood That Parent Would Recommend Laceration Closure MethodSecondary· Post-wound closure, approximately 30 minutes
Parents will be asked to rate how likely they would be to recommend the closure method used for their child using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "Extremely unlikely" and a score of 100 corresponding to "Extremely likely"
Group
Value
95% CI
Absorbable Sutures
99.50
88.00 – 100.00
Steri-Strips
99.00
95.00 – 100.00
Dermabond
99.50
94.50 – 100.00
Number of Complications of the Wound SiteSecondary· 3 months
Parents will be asked by phone at 3 months if there were any complications with their child's cut (infection, opening of the wound, etc.). Investigators will count the number of complications reported.
Group
Value
95% CI
Absorbable Sutures
0
Steri-Strips
0
Dermabond
0
Parental Reported Satisfaction With the Cosmetic Appearance of the ScarSecondary· 3 months
Parents will rate the cosmetic outcome of the laceration using a 0 to 100 mm Visual Analogue Scale with a score of 0 corresponding to "worst scar" and a score of 100 corresponding to "best scar".
Group
Value
95% CI
Absorbable Sutures
70.50
59.75 – 76.75
Steri-Strips
67.00
55.00 – 78.00
Dermabond
85.00
73.00 – 90.00
Presence of Train Tracks at the Scar SiteSecondary· 3 months
Plastic Surgeons will record if a scar appears to have "train tracks" (or small dots on either side of a scar, all along the scar, usually caused by stitches) as they are rating each photo of the scar at 3 months post-closure. Surgeons will answer "yes" or "no".
Group
Value
95% CI
Absorbable Sutures
4
Steri-Strips
4
Dermabond
3
Sponsor's own description
There are several methods of closing a skin cut: stitches, skin glue, and medical tape. Stitches have been used for a long time to close skin cuts. Skin glue (invented in the 1970s) and medical tape (invented in the 1960s) are two newer methods to close skin cuts. The purpose of this study is to find out which method (stitches, skin glue, or medical tape) of closing skin cuts results in the least amount of scarring. Other things the investigators will be looking at are which method is the cheapest, which causes the least pain, which requires the least amount of sedation, and which method patients and parents like the best.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vanderbilt University Medical Center
Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03280628.